Clinical implications of inducible beta-lactamase activity in Gram-negative bacteremia in children

Robert J Boyle1, Nigel Curtis, Nigel Kelly

  • 1Department of Paediatrics, Murdoch Children's Research Institute, Melbourne University, Melbourne, Victoria, Australia. BobBoyle@doctors.org.uk.

Abstract

Insights

Beta-lactam resistance emergence during Extended Spectrum Cephalosporin producing Gram-negative Pathogens (ESCaPPM) sepsis in children is uncommon but can lead to adverse outcomes. Combination therapy with extended spectrum penicillin and aminoglycoside may be preferred over carbapenems or quinolones.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Resistance
  • Hospital-Acquired Infections

Background:

  • Extended Spectrum Cephalosporin producing Gram-negative Pathogens (ESCaPPM) are significant causes of hospital-acquired bacteremia and meningitis in children.
  • These organisms possess the potential for developing beta-lactam resistance during antimicrobial therapy, a phenomenon with potentially adverse clinical consequences.
  • The frequency of beta-lactam resistance development and optimal treatment strategies for ESCaPPM infections in pediatric populations remain understudied.

Purpose of the Study:

  • To determine the incidence of beta-lactam resistance emergence during the treatment of ESCaPPM sepsis in children.
  • To evaluate the optimal therapeutic regimens for pediatric ESCaPPM sepsis, comparing combination antimicrobial therapy and carbapenems.

Main Methods:

  • A retrospective review of case notes and microbiological records was conducted.
  • The study encompassed all cases of ESCaPPM bacteremia and meningitis managed at a tertiary children's hospital over a six-year period.

Main Results:

  • Fifty-eight cases of ESCaPPM sepsis were identified. Beta-lactam resistance emerged in 5% (3 cases) of these patients, leading to adverse clinical outcomes in two instances.
  • Treatment outcomes were comparable between patients receiving carbapenems and those treated with a combination of beta-lactam and aminoglycoside.
  • Prior antimicrobial exposure influenced resistance patterns, with higher rates of cefotaxime resistance observed in children with recent carbapenem, cephalosporin, or penicillin use.

Conclusions:

  • The emergence of beta-lactam resistance during ESCaPPM sepsis treatment is infrequent in this pediatric cohort but carries significant clinical risks.
  • For susceptible isolates, an extended spectrum penicillin combined with an aminoglycoside may be a preferred first-line treatment for ESCaPPM sepsis compared to carbapenems or quinolones.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...